AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G
Agricola
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G
American Journal of Clinical Nutrition, Vol. 70, No. 4, 435-438, October 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

Postprandial response of activated factor VII in elderly women depends on the R353Q polymorphism1,2,3

Louise I Mennen, Moniek PM de Maat, Gert Meijer, Peter Zock, Diederick E Grobbee, Frans J Kok, Cornelis Kluft and Evert G Schouten

1 From the Department of Human Nutrition and Epidemiology, Agricultural University Wageningen, Wageningen, Netherlands; INSERM, Unit 258, Villejuif, France; Gaubius Laboratory, TNO-PG Leiden, Leiden, Netherlands; Unilever Nutrition Centre, Unilever Research Laboratory, Vlaardingen, Netherlands; and the Julius Center for Patient Oriented Research, Utrecht University, Netherlands.

2 Supported by a grant from the Netherlands Organization of Scientific Research (904-61-076) and by Unilever Research Laboratory Vlaardingen.

3 Address reprint requests to LI Mennen, INSERM, Unit 258, 16 Avenue PV Couturier, 94807 Villejuif Cedex, France. E-mail: mennen{at}vjf.inserm.fr.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Activated factor VII (FVIIa) is a very potent coagulant and may be a key determinant of the outcome of a cardiovascular event. The main determinants of FVIIa are the R353Q polymorphism and dietary fat intake, which may have an interactive effect.

Objective: The objective was to investigate whether the response of FVIIa to a fat-rich breakfast varies across genotypes of the R353Q polymorphism.

Design: Ninety-one apparently healthy elderly women (>60 y of age), 56 with the RR genotype and 35 with the RQ or QQ genotype, participated in a randomized, controlled crossover study. Subjects received 5 breakfasts, each on a separate day: 1 low-fat control breakfast and 4 high-fat test breakfasts. Blood samples were taken for measurement of FVIIa at 0800 before each breakfast (fasting) and at 1300 and 1500.

Results: The mean (±SD) fasting FVIIa concentration was 93.3 ± 26.7 U/L in women with the RR genotype, 49.3 ± 19.1 U/L in those with the RQ genotype and 39.5 ± 17.2 U/L in those with the QQ genotype. The mean absolute response to all 4 test breakfasts was 37.0 U/L in those with the RR genotype and 16.1 U/L in those carrying the Q allele (P < 0.001 for difference). Likewise, the FVIIa response relative to fasting FVIIa was significantly higher in women homozygous for the R allele.

Conclusion: This observation may indicate a considerable difference in cardiovascular risk between genotype groups as a result of an increase in FVIIa after a fat-rich diet.

Key Words: Coagulation • diet • genetics • elderly women • factor VIIa • factor VII • cardiovascular risk • R353Q genotypes


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Coagulation factor VII circulates in plasma mainly as an inactive zymogen; {approx}1% of it circulates as activated factor VII (FVIIa). FVIIa is, together with tissue factor, a very potent coagulant, and it is conceivable that a small increase in FVIIa may lead to a pronounced elevation of the risk of a cardiovascular event. This risk may be even more important in elderly people, in whom the prevalence of atherosclerosis is high. Until recently, FVIIa could not be measured. Instead, a functional clotting assay was used (FVII:C), which reflects FVIIa and an unknown part of FVII zymogen. In 2 longitudinal studies a positive association between FVII:c and the risk of fatal ischemic heart disease was observed (1, 2).

In the gene coding for FVII the R353Q polymorphism is the result of a single base change in the codon for amino acid 353 and leads to the replacement of arginine (R) with glutamine (Q) (3). Presence of the Q allele is associated with low concentrations of FVII (3).

Another major determinant of FVIIa is dietary fat intake. Several intervention studies that included mostly small numbers of middle-aged men showed an increase in FVIIa after a fat-rich meal (48). It is not yet clear whether this response of FVIIa to fat intake is affected by the R353Q polymorphism. The only study performed on this included only 8 subjects carrying the Q allele. The results showed an absolute difference in the postprandial FVIIa increase, but no difference between the genotypes was observed when the FVIIa increase was calculated relative to the fasting FVIIa concentration (5). We studied the FVIIa response to fat-rich meals in a large number of apparently healthy elderly women who were selected on the basis of their genotype for the R353Q polymorphism.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Elderly women living independently in retirement communities in Netherlands were asked to participate in the study. The women had to fulfill the following inclusion criteria: were older than 60 y of age, had no diabetes mellitus, had had no myocardial infarction in the year before the investigation, had not used vitamin K antagonists, had not used hormone replacement therapy, and had no medical problems related to fat consumption. The genotype for the R353Q polymorphism was assessed in 321 women. Thirty-five of the 55 women found to carry the Q allele were able to participate and 56 women with the RR genotype were randomly selected. Thus, a total of 91 women were included in the intervention study. The study was approved by the Medical Ethics Committee of the Wageningen Agricultural University and written informed consent was obtained from all participants.

Intervention
Participants received 5 breakfasts, each on a different day. At 0800 (after an overnight fast) the first blood sample was taken and within 0.5 h the subjects ate their breakfast. Additional blood samples were taken at 1300 and 1500. The participants stayed in the same room during the entire procedure and received fat-free foods after the breakfast if they requested them.

All breakfasts had the same total energy content, but 4 breakfasts contained 50% of energy as fat (test breakfast), whereas the control breakfast contained only 1.5% of energy as fat (fat was exchanged for carbohydrates). The test breakfasts consisted of a high-fat bun with 20 g margarine and 30 g jam, 200 mL orange juice, and 67 g cake. The control breakfast consisted of a low-fat bun with 10 g low-fat spread and 30 g jam, 200 mL low-fat yogurt mixed with 65 g energy-rich powder (Caloreen; Clintec, Utrecht, Netherlands), 20 g sugar, 1 cup of tea, and 100 mL energy-rich drink (Nutrical; Nutricia, Zoetermeer, Netherlands). For the purposes of a separate research question, the test breakfasts differed in fatty acid composition (1 was rich in palmitic acid, 1 in oleic acid, and 2 in linoleic and linolenic acids, either with a ratio of 3 to 1 or with a ratio 15 to 1), but we did not observe a difference in FVIIa response between these test breakfasts (9).

Measurements
Blood was collected in siliconized evacuated tubes containing 0.129 mol sodium citrate/L (Becton Dickinson, Meylan, France). Samples were centrifuged for 30 min at 1500 x g and 20°C. Citrated plasma was snap frozen and stored at -80°C until analyzed. FVIIa was measured on an STA instrument (Boehringer, Mannheim, Germany) with a clotting assay using soluble recombinant tissue factor (Staclot; Diagnostica Stago, Asnières, France) (10). The recorded clotting time is inversely related to the FVIIa activity expressed as U/L. The CV of this measurement was 8% and the intraindividual variation (calculated with measurements of 5 fasting blood samples for each person) was 2.09 U/L.

DNA was extracted from mouth swabs according to Meulenbelt et al (11). DNA polymorphisms were determined as described previously (12). Briefly, genomic DNA was amplified by using the polymerase chain reaction with oligonucleotide primers as described by Lane et al (13). The reaction components were incubated at 94°C for 4 min, followed by 32 cycles of 94°C for 1 min, 59°C for 1.5 min, and 72°C for 2 min. Ten milliliters polymerase chain reaction product were digested with 5 U MspI (Gibco BRL, Rockville, MD) at 37°C. MspI digestion yielded a constant 40–base pair (bp) band. The common R allele gave bands of 205 bp and 67 bp and the Q allele gave a band of 282 bp as described previously (3). Because the number of persons with the QQ genotype was too small for meaningful analysis, they were combined with subjects having the RQ genotype.

Data analyses
The response of FVIIa to each meal was calculated by subtraction of the fasting FVIIa concentration from the concentrations at 1300 and 1500. The mean of the responses of FVIIa to the 4 test breakfasts was used in this study because there was no significant difference in response of FVIIa between the test breakfasts (9). To take into account what would have happened without the fat in the meal, the response to the control breakfast at 1500 was subtracted from the mean response to the test breakfasts at 1500. We called this the mean absolute response. The mean relative total response is the mean absolute response as a percentage of the fasting FVIIa concentration. With paired Student's t tests, we evaluated whether the mean absolute and relative total responses differed between the genotype groups. To allow for further adjustment for the fasting concentration of FVIIa, a linear regression analysis was performed with the mean absolute response as the dependent variable and the genotype group and fasting FVIIa concentration as the independent variables. The statistical analysis program SAS (version 6.11; SAS Institute, Cary, NC) was used for the analyses.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
General characteristics of the study population according to genotype are presented in Table 1Go. The frequency of the Q allele in the source population of 321 women was 0.09. Compared with women homozygous for the R allele, fasting FVIIa was 47% lower (49.3 compared with 93.3 U/L) in women with the RQ genotype and 58% lower (39.5 compared with 93.3 U/L) in women homozygous for the Q allele.


View this table:
[in this window]
[in a new window]
 
TABLE 1. General characteristics of the female study population according to genotype1
 
The absolute total response of FVIIa at 1300 and 1500 is shown in Figure 1Go for the genotype groups separately. The mean absolute response of FVIIa was 37.0 U/L in the group with the RR genotype and 16.1 U/L (P < 0.001) in those carrying the Q allele. Note that the R353Q polymorphism was an independent predictor of the FVIIa response even after adjustment for fasting FVIIa concentration in the linear regression model (ß = -11.8 U/L; 95% CI: -20.0,-3.6). The mean relative total response in FVIIa was 42% and 32% (P = 0.01 for difference) in women homozygous for the R allele and in those carrying the Q allele, respectively.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 1. Mean activated factor VII (FVIIa) in elderly women before and after test and control breakfasts according to genotype.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The results of this study in elderly women clearly show that the absolute as well as the relative response to a fat-rich meal depends on the genotype of the R353Q polymorphism. The subjects in this study were selected on the basis of genotype to include similar numbers of women with the RR and RQ or QQ genotypes. The frequency of the Q allele in the source population of 321 women, however, was similar to the frequency reported previously in European whites (12, 14).

The rise in FVIIa found in our study may reflect a true increase in FVIIa or may reflect an increase in the amount of lipids in the blood samples. It may be that the amount of triacylglycerol in the sample influences the measurement of FVIIa. Although there have been a few studies investigating the influence of lipids on the measurement of factor VII:C, none included measurement of FVIIa, and results were inconsistent (5, 15). Furthermore, if the measurement of FVIIa were dependent on the amount of triacylglycerol, we would expect a clear association between serum triacylglycerol and FVIIa in our study. This was not the case, however, in any of the blood sampling occasions (9).

In 5 earlier studies an increase in FVIIa was found after a fat-rich meal (48). Miller et al (4) observed a 19% increase in FVIIa 6.5 h after a high-fat (64% of energy as fat) meal and no response to a low-fat (9% of energy as fat) meal. In a study by Sanders et al (7), it was found that FVIIa increased in response to 90 and 120 g of fat, with a peak at 7 h, but not in response to 15 or 60 g fat. Kapur et al (8) found an increase in FVIIa 6 h after a fat-rich meal (30 g/m2). Two studies by Silveira et al (5, 6) in 31 male postinfarction patients and 24 healthy men showed an increase in FVIIa after 6 h during a fat-tolerance test. The absolute increase in FVIIa was higher in postmyocardial infarction patients with the RR genotype than in patients carrying the Q allele. However, in contrast with our study, the percentage increase in FVIIa did not differ between the genotypes (5). This discrepancy may be explained by different types of subjects: men with myocardial infarction in the study of Silveira et al (5) and healthy elderly women in our study. However, we think it is more likely that Silveira et al (5) did not find a difference in percentage response between the genotypes because they studied a much smaller number of subjects (31, of whom 8 had the RQ genotype).

One of the mechanisms that may explain an effect of dietary fat on factor VII is based on activation of factor VII by negatively charged surfaces during lipolysis of triacylglycerol-rich lipoproteins (16). The fact that our data show differences in activation for the R and Q alleles, independent of the fasting activity of FVIIa, suggest a molecular difference between the 2 types of FVIIa in this respect. The results of our study do not clarify how the R353Q polymorphism could influence the activation of FVII, but it may be that the change in charge ensuing from the substitution of the positively charged arginine with a neutral glutamine affects the interaction of FVII with lipid surfaces (17). Furthermore, the R353Q polymorphism and the -323Ins10 polymorphism in the promoter region of the FVII gene show strong linkage disequilibrium and allelic association (18). Although a polymorphism in the promoter region is more likely to affect basal FVIIa, we cannot exclude the possibility that in fact this polymorphism may cause the difference in the postprandial FVIIa increase.

In conclusion, the results of this study suggest that FVIIa increases profoundly after a fat-rich meal in elderly women with the RR genotype of the R353Q polymorphism. Because this may contribute to the risk of a cardiovascular event or modify its prognosis, a diet with a low to moderate fat intake may be recommendable for elderly subjects with the RR genotype.


    ACKNOWLEDGMENTS
 
We thank all participants of this study for their enthusiastic cooperation. Furthermore, we thank Linda Huisman for the analysis of blood lipids, factor VII, and DNA, and Suzanne van Gaans, Celine van der Hoofd, and Marlon Louisa for their assistance during the data collection.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J Med 1994;87:403–6.[Abstract/Free Full Text]
  2. Junker R, Heinrich J, Schulte H, Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997;17:1539–44.[Abstract/Free Full Text]
  3. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991;11:540–6.[Abstract/Free Full Text]
  4. Miller GJ, Martine JC, Mitropoulos KA, et al. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood 1996;87:4187–96.[Abstract/Free Full Text]
  5. Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994;72:734–9.[Medline]
  6. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triacylglycerol-rich lipoproteins activated coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 1996;16:1333–9.[Abstract/Free Full Text]
  7. Sanders TAB, Miller GJ, de Grassi T, Yahia N. Postprandial activation of coagulant factor VII by long-chain dietary fatty acids. Thromb Haemost 1996;76:369–71.[Medline]
  8. Kapur R, Hoffman CJ, Bhushan V, Hultin MB. Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol 1996;16:1327–32.[Abstract/Free Full Text]
  9. Mennen L, de Maat M, Meijer G, et al. Factor VIIa response to a fat-rich meal does not depend on fatty acid compositions: a randomized controlled trial. Arterioscler Thromb Vasc Biol 1998;18:599–603.[Abstract/Free Full Text]
  10. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993;81:734–44.[Abstract/Free Full Text]
  11. Meulenbelt I, Droog S, Trommelen GJM, Boomsma DI, Slagboom PE. High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations. Am J Hum Genet 1995;57:1252–4.[Medline]
  12. de Maat MPM, Green F, de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997;17:1918–23.[Abstract/Free Full Text]
  13. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992;94:43–50.[Medline]
  14. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994;14:193–8.[Abstract/Free Full Text]
  15. Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993;99:55–61.[Medline]
  16. Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle aged men. Atherosclerosis 1989;76:203–8.[Medline]
  17. Green F, Humphries S. Genetic determinants of arterial thrombosis. Baillieres Clin Haematol 1994;7:675–92.[Medline]
  18. Humphries S, Temple A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996;75:567–72.[Medline]
Received for publication November 5, 1998. Accepted for publication March 9, 1999.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
I. A. Ghiu, R. E. Ferrell, O. Kulaputana, D. A. Phares, and J. M. Hagberg
Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training
J Appl Physiol, March 1, 2004; 96(3): 985 - 990.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G
Agricola
Right arrow Articles by Mennen, L. I
Right arrow Articles by Schouten, E. G


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS